New Publications From Agios Pharmaceuticals Scientists and Collaborators Reveal Unexpected Regulation of Metabolic Pathways in Cancer
9/20/2012 10:06:11 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases, announced today two recent publications that provide important new validation for the emerging field of cancer metabolism. The article “Phosphofructokinase 1 Glycosylation Regulates Cell Growth and Metabolism” was published in the August 24, 2012 issue of the journal Science, and the article “Small molecule activation of PKM2 in cancer cells induces serine auxotrophy” will be published in the September 21, 2012 issue of the journal Chemistry & Biology.
comments powered by